What does this research mean for the field?

Hypoxia-induced stabilization of the transcription factor BACH1 aggravates pulmonary hypertension by promoting vascular remodeling through the activation of the TGFBR2/SMAD signaling pathway in smooth muscle cells. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research investigates the role of BACH1 in the development of pulmonary hypertension and its underlying mechanisms.

May 27, 2026Circulation

Hypoxia Upregulation of BACH1 Aggravates Pulmonary Hypertension Through TGFBR2/SMAD Pathways

View Full Paper

Ask AI

Bookmark

Authors

YHYannan Hou QLQinhan Li TWTong‐You Wade Wei

Discussion

Member takes

Overview

Randomized trial shows activation of BACH1 worsens pulmonary hypertension, suggesting new treatment targets.

Key Points

This research investigates the role of BACH1 in the development of pulmonary hypertension and its underlying mechanisms.
Utilized coimmunoprecipitation assay to study BACH1 modification.
Analyzed cultured pulmonary artery smooth muscle cells and rodent models of pulmonary hypertension.
Conducted single-nucleus RNA sequencing on lung tissues from patients with idiopathic pulmonary arterial hypertension.
BACH1 levels were significantly increased in PH model animals and patient samples.
Hypoxia reduced BACH1 prolyl hydroxylation, enhancing its stability and promoting its activity.
Inhibition of TGFBR2 kinase activity decreased extracellular matrix gene expression linked to BACH1.

Cite This Study

Hou et al. (2026) studied this question.

synapsesocial.com/papers/6a170b7883575dabbb9ab601 https://doi.org/10.1161/circulationaha.124.073606

View Full Paper

Ask AI

Bookmark

May 27, 2026Circulation

Hypoxia Upregulation of BACH1 Aggravates Pulmonary Hypertension Through TGFBR2/SMAD Pathways

View Full Paper

Ask AI

Bookmark

Authors

YHYannan Hou QLQinhan Li TWTong‐You Wade Wei

Discussion

Member takes

Overview

Randomized trial shows activation of BACH1 worsens pulmonary hypertension, suggesting new treatment targets.

Key Points

This research investigates the role of BACH1 in the development of pulmonary hypertension and its underlying mechanisms.
Utilized coimmunoprecipitation assay to study BACH1 modification.
Analyzed cultured pulmonary artery smooth muscle cells and rodent models of pulmonary hypertension.
Conducted single-nucleus RNA sequencing on lung tissues from patients with idiopathic pulmonary arterial hypertension.
BACH1 levels were significantly increased in PH model animals and patient samples.
Hypoxia reduced BACH1 prolyl hydroxylation, enhancing its stability and promoting its activity.
Inhibition of TGFBR2 kinase activity decreased extracellular matrix gene expression linked to BACH1.

Cite This Study

Hou et al. (2026) studied this question.

synapsesocial.com/papers/6a170b7883575dabbb9ab601 https://doi.org/10.1161/circulationaha.124.073606

View Full Paper

Ask AI

Bookmark